Overview

• Animal health biologics firm's preliminary Q2 product sales rose 11.5% yr/yr

• Growth driven by 27.7% increase in domestic sales, while international sales declined 38.9%

• Company cites robust U.S. demand and improved product availability for sales increase

Outlook

• Company did not provide specific guidance for future quarters or full-year results

Result Drivers

• DOMESTIC SALES SURGE - Co said 27.7% increase in domestic sales drove overall Q2 growth

• PRODUCT AVAILABILITY - Management cited excellent product availability as supporting strong sales

• COMMERCIAL EFFORTS - Targeting year-round, price-sensitive dairy customers and expanding commercial team contributed to growth in Dual-Force and Tri-Shield sales

Company press release: ID:nGNX1ZmM4M

Key Details

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.